The purpose of this study was to compare influenza vaccination rates of pregnant women in a public safety-net health system to national coverage rates during the 2009-2010 pandemic influenza season. A chart review of a random sample of deliveries was undertaken to determine rates of coverage and predictors of vaccine coverage of women who obtained prenatal care and delivered in our health system. Rates were calculated from deliveries from when the vaccine was first available through April 30, 2010. Coverage rates were 54% for the seasonal influenza vaccine and 51% for the H1N1 vaccine. Race/ethnicity, insurance status and language spoken did not predict the receipt of either vaccine. When we included only births which occurred through March 12, 2010, as was done in a large population-based study, the rates were 61% and 59%, respectively. Our rates are about 10% higher than the rates reported in that study. Our comprehensive strategy for promoting vaccine coverage achieved higher vaccination rates in a safety-net health system, which serves groups historically less likely to be vaccinated, than those reported for the pregnant population at large. 1. Introduction Currently the influenza vaccine is recommended in the United States for all individuals over 6 months of age [1] and by the World Health Organization for high-risk groups [2]. These recommendations have, in part, the aim to reduce the worldwide estimated deaths 250,000–500,000 each year caused by the seasonal form of the disease [3]. Pregnant women are included in these recommendations because vaccination with the inactivated virus has been shown to decrease the burden of suffering among neonates [4–6] and to reduce maternal morbidity of the infection [7]. Furthermore, vaccination in pregnancy has been documented as sufficiently safe to be recommended to be given regardless of trimester [4, 8]. Despite these recommendations in pregnancy, coverage of pregnant women in the United States has been low in the years prior to the 2009-2010 influenza season (11% to 24%) [7]. Reasons cited for this include not being offered the vaccine, not having the vaccine in the office, and maternal concerns for vaccine safety [9, 10]. In the spring of 2009, a new swine-origin form of the influenza A virus, causing substantial morbidity and mortality, was isolated: H1N1 [11]. As part of the pandemic strategy for this virus, a specific monovalent vaccine for H1N1 was developed and was ready for distribution in the Fall of 2009 [12]. Among the high-risk groups targeted to receive this vaccine, in addition to the
References
[1]
L. Grohskopf, T. Uyeki, J. Bresee, N. Cox, and C. Bridges, “Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP),” Morbidity and Mortality Weekly Report, vol. 60, no. 33, pp. 1128–1132, 2011.
Global view of pandemic and seasonal influenza disease burden, 2011, http://203.127.83.146/hosting/flu/speakers/NahokoShindo.pdf.
[4]
ACOG Committee Opinion No. 468, “Influenza vaccination during pregnancy,” Obstetrics and Gynecology, vol. 116, no. 4, pp. 1006–1007, 2010.
[5]
K. Zaman, E. Roy, S. E. Arifeen et al., “Effectiveness of maternal influenza immunization in mothers and infants,” The New England Journal of Medicine, vol. 359, no. 15, pp. 1555–1564, 2008.
[6]
A. A. Eick, T. M. Uyeki, A. Klimov et al., “Maternal influenza vaccination and effect on influenza virus infection in young infants,” Archives of Pediatrics and Adolescent Medicine, vol. 165, no. 2, pp. 104–111, 2011.
[7]
A. E. Fiore, T. M. Uyeki, K. Broder et al., “Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010,” Morbidity and Mortality Weekly Report, vol. 59, no. 8, pp. 1–62, 2010.
[8]
P. D. Tamma, K. A. Ault, C. del Rio, M. C. Steinhoff, N. A. Halsey, and S. B. Omer, “Safety of influenza vaccination during pregnancy,” American Journal of Obstetrics and Gynecology, vol. 201, no. 6, pp. 547–552, 2009.
[9]
I. B. Ahluwalia, D. J. Jamieson, S. A. Rasmussen, D. D'Angelo, D. Goodman, and H. Kim, “Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island,” Obstetrics and Gynecology, vol. 116, no. 4, pp. 949–955, 2010.
[10]
B. Gonik, T. Jones, D. Contreras, N. Fasano, and C. Roberts, “The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization,” Obstetrics and Gynecology, vol. 96, no. 1, pp. 81–84, 2000.
[11]
F. S. Dawood, S. Jain, L. Finelli et al., “Emergence of a novel swine-origin influenza A (H1N1) virus in humans,” The New England Journal of Medicine, vol. 360, no. 25, pp. 2605–2615, 2009.
[12]
Use of influenza A (H1N1), “Monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP),” Morbidity and Mortality Weekly Report, vol. 58, no. 10, pp. 1–8, 2009.
[13]
S. A. Rasmussen, D. J. Jamieson, and J. S. Bresee, “Pandemic influenza and pregnant women,” Emerging Infectious Diseases, vol. 14, no. 1, pp. 95–100, 2008.
[14]
D. J. Jamieson, M. A. Honein, S. A. Rasmussen et al., “H1N1 2009 influenza virus infection during pregnancy in the USA,” The Lancet, vol. 374, no. 9688, pp. 451–458, 2009.
[15]
J. K. Louie, M. Acosta, D. J. Jamieson, and M. A. Honein, “Severe 2009 H1N1 influenza in pregnant and postpartum women in California,” The New England Journal of Medicine, vol. 362, no. 1, pp. 27–35, 2010.
[16]
S. Jain, L. Kamimoto, A. M. Bramley et al., “Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009,” The New England Journal of Medicine, vol. 361, no. 20, pp. 1935–1944, 2009.
[17]
M. Pierce, J. J. Kurinczuk, P. Spark, P. Brocklehurst, and M. Knight, “Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study,” BMJ, vol. 342, no. 7811, Article ID d3214, 2011.
[18]
M. W. Varner, M. M. Rice, B. Anderson et al., “Influenza-like illness in hospitalized pregnant and postpartum women during the 2009-2010 H1N1 pandemic,” Obstetrics and Gynecology, vol. 118, no. 3, pp. 593–600, 2011.
[19]
“Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women—10 states, 2009-10 influenza season,” Morbidity and Mortality Weekly Report, vol. 59, no. 47, pp. 1541–1545, 2010.
[20]
D. K. Walker, S. Ball, R. Black, et al., “Influenza vaccination coverage among pregnant women: United States, 2010-11 Influenza Season,” Morbidity and Mortality Weekly Report, vol. 60, no. 32, pp. 1078–1082, 2011.
[21]
S. Cox, S. F. Posner, M. McPheeters, D. J. Jamieson, A. P. Kourtis, and S. Meikle, “Influenza and pregnant women: hospitalization burden, United States, 1998–2002,” Journal of Women's Health, vol. 15, no. 8, pp. 891–893, 2006.
[22]
P. Lu, C. B. Bridges, G. L. Euler, and J. A. Singleton, “Influenza vaccination of recommended adult populations, U.S., 1989–2005,” Vaccine, vol. 26, no. 14, pp. 1786–1793, 2008.
[23]
H. Ding, T. A. Santibanez, D. J. Jamieson et al., “Influenza vaccination coverage among pregnant womenNational 2009 H1N1 Flu Survey (NHFS),” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement, pp. S96–S106, 2011.
[24]
G. K. Steelfisher, R. J. Blendon, M. M. Bekheit et al., “Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers,” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement, pp. S116–S123, 2011.
[25]
B. M. Fisher, J. Scott, J. Hart, V. D. Winn, R. S. Gibbs, and A. M. Lynch, “Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy,” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement, pp. S107–S111, 2011.
[26]
L. O. Eckert and K. K. Hoppe, “Achieving high coverage of H1N1 influenza vaccine in an ethnically diverse obstetric population: success of a multifaceted approach,” Infectious Diseases in Obstetrics and Gynecology, vol. 2011, Article ID 746214, 5 pages, 2011.
[27]
I. Goldfarb, B. Panda, B. Wylie, and L. Riley, “Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic,” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement, pp. S112–S115, 2011.
[28]
D. Fridman, E. Steinberg, E. Azhar, J. Weedon, T. E. Wilson, and H. Minkoff, “Predictors of H1N1 vaccination in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement, pp. S124–S127, 2011.
[29]
S. Gracie, A. Metcalfe, S. M. Dolan, H. Kehler, J. Siever, and S. Tough, “Utilization of the 2009 H1N1 vaccine by pregnant women in a pandemic year,” Journal of Obstetrics and Gynaecology Canada, vol. 33, no. 2, pp. 127–133, 2011.
[30]
P. Fabry, A. Gagneur, and J.-C. Pasquier, “Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec,” Vaccine, vol. 29, no. 9, pp. 1824–1829, 2011.
[31]
R. Freund, C. Le Ray, C. Charlier et al., “Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort study,” PLoS One, vol. 6, no. 6, Article ID e20900, 2011.
[32]
A. Bone, J. P. Guthmann, J. Nicolau, and D. Lévy-Bruhl, “Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign,” Vaccine, vol. 28, no. 51, pp. 8157–8161, 2010.
[33]
D. B. Mak, A. M. Daly, P. K. Armstrong, and P. V. Effler, “Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia,” Medical Journal of Australia, vol. 193, no. 7, pp. 401–404, 2010.
[34]
Health and Human Services. Healthy People 2020: immunization and infectious disease, 2011, http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=23.
[35]
T. Ogburn, E. L. Espey, V. Contreras, and P. Arroyo, “Impact of clinic interventions on the rate of influenza vaccination in pregnant women,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 52, no. 9, pp. 753–756, 2007.
[36]
B. Panda, R. Stiller, and A. Panda, “Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, no. 3, pp. 402–406, 2011.
[37]
D. H. Wallis, J. L. Chin, D. K. C. Sur, and M. Y. Lee, “Increasing rates of influenza vaccination during pregnancy: a multisite interventional study,” Journal of the American Board of Family Medicine, vol. 19, no. 4, pp. 345–349, 2006.